<DOC>
	<DOC>NCT02924337</DOC>
	<brief_summary>The purpose of this study is to assess the effect of a single therapeutic dose and a single supra-therapeutic dose of imeglimin on the QT/QTc interval</brief_summary>
	<brief_title>Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>healthy volunteers BMI between 18.5 and 29.9 kg/m2 weighing between 55 and 95 kg willing to use reliable contraception able to give fully informed written consent. Pregnant or lactating woman, or sexually active woman of childbearing potential not using highly effective contraception clinically relevant abnormal medical history, surgery or concurrent medical condition; acute or chronic illness clinically significant QT/QTc interval prolongation at Baseline history of druginduced or risk factors for Torsade de Pointes any contraindication to moxifloxacin severe adverse reaction to any drug or sensitivity to the trial medication or its components significant food allergy; use of vitamins, herbal medicines, prescription or overthecounter medication (with the exception of paracetamol [acetaminophen] and oral contraceptives for women) within 20 days or 6 halflives before first dose of trial medication participation in other clinical trials of unlicensed or prescription medicines, or loss of more than 400 mL blood, within the 3 months before first dose of trial medication drug or alcohol abuse; smoking of more than 5 cigarettes, 1 cigars or 1 pipes daily regular consumption of more than 5 cups of caffeinated drinks per day positive test for hepatitis A, B &amp; C, HIV objection by a General Practitioner.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>QT/QTC interval</keyword>
	<keyword>Hypoglycemic Agents</keyword>
	<keyword>Imeglimin</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>